STC2 and neoplasm: For reference, STC2, a downstream target of miR-361-3p, was shown to promote tumor invasion and migration via the Wnt/β-catenin signaling pathway in vivo experiments (38), while SNHG17 acts as a ceRNA for miR-361-3p (36).